Abstract
Objective
Premature aging and short telomere lengths of fetal tissues are associated with spontaneous preterm labor (PTL) and preterm premature rupture of membranes (pPROM). Maintenance of telomere length is performed by the enzyme telomerase. Human telomerase reverse transcriptase (hTERT) is a subunit of telomerase, and its dysfunction affects telomere shortening. This study assessed whether maternal or fetal genetic variations in the hTERT gene are associated with PTL or pPROM.
Methods
A case (PTL or pPROM) control (term birth) genetic association study was conducted in 654 non-Hispanic white mothers (438 term, 162 PTL, 54 pPROM) and 502 non-Hispanic white newborns (346 term, 116 PTB, 40 pPROM). Maternal and fetal DNA samples were genotyped for 23 single nucleotide polymorphisms (SNPs) within the hTERT gene. Allele frequencies were compared between cases and controls, stratified by PTL and pPROM. Maternal and fetal data were analyzed separately.
Results
Allelic differences in one SNP of hTERT (rs2853690) were significantly associated with both PTL (adjusted OR 2.24, 95%CI 1.64–3.06, p = 2.32e-05) and with pPROM (adjusted OR 7.54, 95%CI 3.96–14.33, p = 2.39e-07) in maternal DNA. There was no significant association between the hTERT SNPs analyzed and PTL or pPROM in the fetal samples.
Conclusion
hTERT polymorphisms in fetal DNA do not associate with PTL or pPROM risk; however, maternal genetic variations in hTERT may play a contributory role in risk of PTL and PPROM.
Background
Preterm birth (PTB) is the leading cause of neonatal morbidity and mortality.[1] It complicates 5–12% of pregnancies[2], and infant sequelae include respiratory distress syndrome, necrotizing enterocolitis, intraventricular hemorrhage, and sepsis, among many others. While some preterm births are medically indicated for either maternal or fetal benefit, others are spontaneous (preterm labor [PTL] or preterm premature rupture of membranes [pPROM]). The precise biological signals and mechanisms that determine human parturition, term or preterm, continue to be poorly understood. There are likely multiple and redundant pathways that converge on the phenotype of preterm and term parturition.[3] One of the mechanisms initiating parturition that our laboratory has reported recently is fetal membrane cell senescence. The core hypothesis is that fetal amnion and chorion senescence and senescence-associated inflammation is the initiator of a coordinated cascade leading to parturition.[4]
Evidence for fetal membrane senescence has been accumulating. In the second half of pregnancy, there is a gestational age-dependent reduction in telomere length of fetal leukocytes, which has been shown to strongly correlate with telomere length of fetal membrane cells.[5] At term, labor is associated with accelerated telomere shortening in fetal membrane tissues.[6] It is thought that the oxidative stress and inflammation of labor contributes to telomere attrition. Behnia et al reported increases in several markers of senescence from pregnancies in labor compared to those sampled prior to the onset of labor.[7] To establish causality, the same group established an in-vitro model of fetal membrane organ explant cultures and primary amnion epithelial cells from term not-in-labor tissue that showed oxidative stress induces acceleration of telomere shortening and senescence and produces significant inflammation.[6]
Replicative senescence is a telomere-dependent aging process that associates with a reduced risk of cancer.[8,9] Telomeres are guanine rich caps on the ends of chromosomes that function to protect chromosome integrity. Telomeres shorten over time due to incomplete replication with each cell cycle, and therefore telomere length is one marker of cell aging.[10,11] Telomere dysfunction is thought to be one of many signals that can induce premature cell senescence.[9,11] Telomerase is the enzyme that maintains telomere length (thereby postponing cell-cycle arrest) by adding nucleoside repeat sequences to the 3 prime end of DNA.[12] It is made of two components: the human RNA subunit that acts as the template and the human telomerase reverse transcriptase (hTERT), that adds the nucleosides.[10]
There is a robust literature describing hTERT polymorphisms associated with phenotypes of both slowed aging, such as cancer,[13–16] as well as accelerated aging, such as cardiovascular diseases.[17–21] Specifically, shortened telomere length has been shown to be associated with carotid atherosclerosis,[17] stroke, myocardial infarction, type 2 diabetes,[18] and coronary artery disease.[19,22] Haycock et al recently published a large genome wide association study (GWAS) that showed a protective effect of genetically increased telomere length on the development of coronary heart disease and abdominal aortic aneurysm, as well as other non-cardiovascular diseases.[22]
It is thought that the association of hTERT polymorphisms and clinical disease is mediated through changes in telomere length. A few studies have shown associations between changes in telomere length and genetic variants of hTERT,[15,23] as well as other genes.[24] These studies suggest that, in addition to aging, genetic factors influence telomere length.
Fetal tissue telomere length differences are also associated with adverse pregnancy outcomes. In pregnancies affected by pPROM, fetal leukocytes had significantly shorter telomeres, compared to gestational age matched samples from PTL.[5] The telomere lengths are also smaller than those from the term birth samples. This suggests that dysfunctional or accelerated aging of fetal membranes, evidenced by shorter telomeres, may contribute to pPROM. It also may indicate that the aging mechanism leading to pPROM differs from that leading to PTL with intact membranes.[25]
To summarize, normal aging of fetal cells is a physiologic process linked to term parturition. However, accelerated telomere shortening is linked to premature aging and adverse pregnancy outcomes, including pPROM. It has been hypothesized that telomere shortening acts as a biologic clock, affecting the timing of labor.[4] Because telomerase regulates telomere length, perhaps the accelerated telomere shortening seen in pPROM is related to reduced fetal telomerase activity. It has also been suggested that maternal decidual senescence plays a role in the mechanisms of parturition,[26] and therefore maternal telomerase activity may contribute to the phenotype of spontaneous preterm birth, as well.
There is ample evidence that genetics plays a role in the phenotype of preterm birth.[27–29] While hTERT polymorphisms have been shown to be associated with certain types of cancers,[13–15] and other diseases,[17–19,22] there have been no genetic association studies investigating the association of hTERT polymorphisms and PTL or pPROM. hTERT has a biologically plausible role in spontaneous preterm birth via the fetal cell senescence pathway.
Our data thus far suggests that the two phenotypes of spontaneous PTL and pPROM are due to different aging mechanisms, maybe even in different tissues. The purpose of this study was to determine if maternal or fetal genetic variations (single nucleotide polymorphisms [SNPs]) in the hTERT gene are associated with PTL or pPROM.
Materials and methods
Study design
Institutional review boards at TriStar Nashville, TN and The University of Texas Medical Branch at Galveston, TX, approved this study. Subjects provided informed written consent to use their biological specimens for various studies related to preterm birth. Genotype and covariate data can be found in the Supplement (S1 Table).
We performed a case control genetic association study in women and newborns with PTL or pPROM compared to those with term birth. This study utilized previously banked samples from the Nashville Birth Cohort, which recruited women from the Centennial Medical Center in Nashville, TN between September 2003 and December 2006. The methods have been previously reported,[28] but briefly, the original cohort inclusion criteria were women aged 18–40 years with a singleton, live birth. Women were excluded if their pregnancy was complicated by multiple gestation, preeclampsia, placenta previa, fetal anomalies, gestational diabetes, polyhydramnios, oligohydramnios, or surgery. Our analyses further excluded women or newborns with missing genotypes. Racial disparity in genetic predisposition to both preterm birth[29] and telomere length[30–31] has been reported previously; in addition, our biobank had low numbers of remaining non-Caucasian samples. Hence, our study was restricted to the Caucasian population.
Cases of PTL were defined as delivery at less than 36 0/7 weeks gestation preceded by preterm labor with intact membranes. Cases of pPROM were defined as delivery at less than 36 0/7 weeks gestation preceded by premature rupture of membranes. A cut-off of 36 0/7 weeks gestation was used to correct for the lack of precision of pregnancy dating and to ensure a truly different phenotype than those with term birth. Controls were women or newborns with term birth, defined as 37 0/7 weeks of gestation or more.
Methods
Demographic and clinical data were obtained from questionnaires and medical records. Gestational age was determined by last menstrual period and corroborated by ultrasound dating. Race was determined by self-report and a questionnaire that traces ethnicity back two generations from the parents.
Maternal blood was collected at the time of admission for delivery either at term or preterm, and cord blood was collected at delivery. DNA was isolated from maternal and neonatal cord blood using the Autopure automated system (Gentra Systems, Minnesota, MN). 23 SNPs from the hTERT gene were genotyped using the Sequenom platform (Table 1). Those SNPs that genotyped with low efficiency on Sequenom were re-genotyped using Taqman assays; this occurred with one SNP: rs2736100. We chose tagSNPs in low linkage disequilibrium using the website https://snpinfo.niehs.nih.gov/. For quality control, SNPs were not analyzed if they deviated from the Hardy-Weinberg equilibrium (p<0.001), had a low minor allele frequency (<0.05), or had low genotyping efficiency (<0.95).
Table 1. hTERT SNPs that were genotyped for maternal and fetal analyses and those that were excluded from analysis.
| hTERT SNP | Included in maternal analyses? | Reason for exclusion from maternal analyses | Included in fetal analyses? | Reason for exclusion from fetal analyses |
|---|---|---|---|---|
| rs2736114 | Y | NA | Y | NA |
| rs2075786 | Y | NA | Y | NA |
| rs4246742 | Y | NA | Y | NA |
| rs4975605 | Y | NA | Y | NA |
| rs10069690 | Y | NA | Y | NA |
| rs2242652 | Y | NA | Y | NA |
| rs2853677 | Y | NA | Y | NA |
| rs2853672 | Y | NA | Y | NA |
| rs2853690 | Y | NA | N | Low GE |
| rs2853676 | Y | NA | N | Deviated from HWE |
| rs2736098 | N | Low GE | N | Low GE |
| rs121918664 | N | Low MAF | N | Low MAF |
| rs35719940 | N | Low MAF | N | Low MAF |
| rs387907251 | N | Low MAF | N | Low MAF |
| rs121918666 | N | Low MAF | N | Low MAF |
| rs199422301 | N | Low MAF | N | Low MAF |
| rs121918663 | N | Low MAF | N | Low MAF |
| rs387907249 | N | Low MAF | N | Low MAF |
| rs199422297 | N | Low MAF | N | Low MAF |
| rs199422294 | N | Low MAF | N | Low MAF |
| rs34094720 | N | Low MAF | N | Low MAF |
| rs121918661 | N | Low MAF | N | Low MAF |
| rs387907247 | N | Low MAF | N | Low MAF |
SNP: single nucleotide polymorphism, GE: genotyping efficiency, MAF: minor allele frequency, HWE: Hardy-Weinberg equilibrium
Statistical analysis
We performed 4 separate case-control analyses as PTL and pPROM were analyzed separately and maternal and fetal DNA were also analyzed separately. All analyses assumed an additive genetic model.
Maternal demographic and maternal and neonatal outcome data were compared between cases and controls using student’s t, Chi-squared, or Mann-Whitney U tests, where appropriate. These tests were performed using R software. Allele frequencies for each SNP were compared between cases and controls using Chi-squared test. We then performed logistic regression analysis (PLINK v1.07) to determine the association of each SNP with the outcome of interest, adjusting for baseline variables that are known risk factors for the outcome of interest, or differed on simple comparison between cases and controls with a p value of less than 0.05. For each regression analysis, p-values thresholds were chosen using the Bonferroni correction for multiple comparisons.
Results
The original cohort had 3,496 participants, including both maternal and fetal samples. In our nested case-control study, for the maternal univariate analyses, there were 162 cases of PTL, 54 cases of pPROM, and 438 controls. For the fetal univariate analyses, there were 116 cases of PTL, 40 cases of pPROM, and 346 controls.
SNP filtering
Of the 23 SNPs chosen for our study, 13 were excluded from the maternal analyses (12 for low minor allele frequency and 1 for low genotyping efficiency), leaving 10 SNPs for analysis. In the fetal analyses, 15 SNPs were excluded (12 for low minor allele frequency, 2 for low genotyping efficiency, and 1 for deviation from the Hardy Weinberg equilibrium), leaving 8 for analysis (Table 1). The average genotyping rate in the remaining SNPs was 0.99.
Baseline characteristics
Maternal and newborn baseline characteristics are described in Tables 2 and 3. As expected, significant differences between cases and controls were observed for gestational age, birth weight, and several measures of socioeconomic status. APGAR scores were better for controls, also as expected. A detailed description of the distribution of APGAR scores can be found in the Supplement (S2 and S3 Tables).
Table 2. Baseline characteristics of maternal cases and controls.
| Maternal Controls N = 438 | Maternal PTL Cases N = 162 | P value | Maternal pPROM Cases N = 54 | P value | ||
|---|---|---|---|---|---|---|
| Maternal age (y) | 28.4 ± 5.8 | 27.6 ± 5.8 | 0.13 | 25.8 ± 5.7 | 0.004 | |
| Nulliparity | 31% (134) | 30% (48) | 0.90 | 39% (21) | 0.28 | |
| Weight (pounds) | 153 ± 37 | 164 ± 48 | 0.02 | 149 ± 47 | 0.004 | |
| Education | <0.001 | <0.001 | ||||
| <12 years | 58% (252) | 93% (150) | 96% (52) | |||
| ≥ 12 years | 42% (186) | 7% (12) | 4% (2) | |||
| Income | <0.001 | <0.001 | ||||
| <15K | 18% (79) | 33% (53) | 48% (26) | |||
| 15–25K | 18% (79) | 11% (18) | 4% (2) | |||
| 25–50K | 25% (111) | 36% (59) | 33% (18) | |||
| 50–100K | 26% (116) | 18% (29) | 13% (7) | |||
| >100K | 9% (40) | 2% (3) | 0% (0) | |||
| Marital Status | 0.38 | <0.001 | ||||
| Unmarried | 23% (102) | 29% (47) | 48% (26) | |||
| Married | 72% (315) | 67% (109) | 50% (27) | |||
| Not recorded | 3% (12) | 2% (4) | 0% (0) | |||
| Insured | 78% (342) | 93% (151) | <0.001 | 96% (52) | 0.003 | |
| Smoker | 12% (52) | 19% (31) | 0.03 | 16% (10) | 0.23 | |
| Birth weight (grams) | 3376 ± 526 | 2420 ± 824 | <0.001 | 2288 ± 1074 | <0.001 | |
| Neonatal female sex | 46% (200) | 43% (69) | 0.99 | 48% (26) | 0.04 |
PTL: preterm labor, pPROM: preterm premature rupture of membranes
Table 3. Baseline characteristics of fetal cases and controls.
| Controls N = 438 | Infant PTL Cases N = 162 | P value | Infant pPROM Cases N = 40 | P value | ||
|---|---|---|---|---|---|---|
| Maternal age (y) | 28.3 ± 5.9 | 28.4 ± 5.7 | 0.88 | 26.6 ± 6.4 | 0.11 | |
| Nulliparity | 24% (107) | 19% (31) | 0.50 | 30% (12) | 1.0 | |
| Weight (pounds) | 154 ± 38 | 161 ± 46 | 0.17 | 155 ± 43 | 0.97 | |
| Education | <0.001 | <0.001 | ||||
| <12 years | 45% (197) | 65% (105) | 93% (37) | |||
| ≥ 12 years | 34% (150 | 6% (10) | 7% (3) | |||
| Income | 0.03 | 0.003 | ||||
| <15K | 15% (64) | 19% (30) | 40% (16) | |||
| 15–25K | 16% (68) | 12% (19) | 18% (7) | |||
| 25–50K | 20% (86) | 25% (40) | 28% (11) | |||
| 50–100K | 21% (92) | 14% (22) | 10% (4) | |||
| >100K | 6% (28) | 2% (4) | 0% (0) | |||
| Marital Status | 0.45 | 0.003 | ||||
| Unmarried | 20% (86) | 22% (35) | 50% (20) | |||
| Married | 55% (243) | 45% (73) | 45% (18) | |||
| Insured | 61% (269) | 64% (104) | 0.004 | 93% (37) | 0.05 | |
| Smoker | 10% (45) | 15% (24) | 0.05 | 28% (11) | 0.03 | |
| Birth weight (grams) | 3353 ± 506 | 2611 ± 768 | <0.001 | 2640 ± 969 | <0.001 | |
| Neonatal female sex | 38% (165) | 31% (51) | 0.80 | 63% (25) | 0.03 |
PTL: preterm labor, pPROM: preterm premature rupture of membranes
Maternal SNP and PTL association
The maternal SNP minor allele frequencies among 162 PTL cases and 438 controls and the results of univariate analysis may be found in the supplement (S4 Table). For the maternal analyses, using the Bonferroni correction for multiple comparisons, the threshold for significance was set at p <0.005.
Of the 10 maternal SNPs analyzed, one (rs2853690) was associated with PTL in the unadjusted model (OR 2.42, 95%CI 1.93–3.05, p = 8.10e-11) (S4 Table). Logistic regression analysis was also performed to assess the association with PTL after adjusting for possible confounders (Table 4). The model adjusted for maternal weight, education (graduate high school or not), income (annual <$15,000, $15,000–24,999, $25,000–49,999, $50,000–99,999, or ≥$100,000), smoking status (Y/N), and insurance status (Y/N). 105 cases and 389 controls were included in the logistic regression, after removing 57 cases and 49 controls with missing covariate data. The SNP, rs2853690, remained significant in the adjusted model (aOR 2.24, 95% CI 1.64–3.06, p = 2.32e-05). No other SNPs were significant after multiple testing correction in either the adjusted or the unadjusted models.
Table 4. Logistic regression results for maternal single locus allele frequencies among cases and controls and association with preterm labor.
| SNP | Minor allele | MAF Term | MAF PTL | aOR (95% CI) | P value |
|---|---|---|---|---|---|
| rs2853690 | A | 0.26 | 0.46 | 2.24 (1.64–3.06) | 2.32E-05 |
| rs2736114 | T | 0.27 | 0.26 | 0.97 (0.71–1.34) | 0.8897 |
| rs2075786 | A | 0.37 | 0.39 | 0.86 (0.65–1.14) | 0.3756 |
| rs4246742 | A | 0.15 | 0.17 | 0.87 (0.60–1.25) | 0.5247 |
| rs4975605 | A | 0.47 | 0.48 | 1.21 (0.91–1.60) | 0.2666 |
| rs10069690 | T | 0.27 | 0.27 | 0.97 (0.71–1.32) | 0.859 |
| rs2242652 | A | 0.19 | 0.20 | 1.27 (0.90–1.78) | 0.261 |
| rs2853677 | G | 0.45 | 0.42 | 0.84 (0.65–1.10) | 0.2912 |
| rs2853676 | T | 0.23 | 0.29 | 0.91 (0.68–1.22) | 0.5973 |
| rs2853672 | C | 0.51 | 0.46 | 0.75 (0.56–1.01) | 0.1062 |
Model adjusted for maternal weight, education, income, smoking status, and insurance status.
SNP: single nucleotide polymorphism, MAF: minor allele frequency, PTL: preterm labor, aOR: adjusted odds ratio, CI: confidence interval
Maternal SNP and pPROM association
The maternal SNP minor allele frequencies among 54 pPROM cases and 438 controls and the results of univariate analysis can be found in the supplement (S5 Table). Using the Bonferroni correction for multiple comparisons, the threshold for significance was set at p <0.005.
Of the 10 maternal SNPs analyzed, the same SNP that was associated with PTL, rs2853690, was also associated with pPROM on univariate comparison (OR 4.59, 95% CI 3.18–6.62, p = 3.0e-13), as well as one additional SNP, rs2736114 (OR 2.08, 95% CI 1.48–2.93, p = 0.0003) (S5 Table). Logistic regression analysis was also performed to assess the association with pPROM after adjusting for possible confounders (Table 5). Models adjusted for maternal age, education (graduate high school or not), income (annual <$15,000, $15,000–24,999, $25,000–49,999, $50,000–99,999, or ≥$100,000), marital status, smoker (Y/N), insurance status (Y/N), and sex of the infant. 32 cases and 368 controls were included in the logistic regression, after removing 22 cases and 70 controls with missing covariate data. Of the two SNPs that were significant on univariate analysis, only SNP rs2853690, the same one that was independently associated with PTL, remained significantly associated with pPROM (aOR 7.54, 95% CI 3.96–14.33, p = 2.39e-07)
Table 5. Logistic regression results for maternal single locus allele frequencies among cases and controls and association with preterm premature rupture of membranes.
| SNP | Minor allele | MAF Term | MAF pPROM | aOR (95% CI) | P value |
|---|---|---|---|---|---|
| rs2853690 | A | 0.26 | 0.61 | 7.54 (3.96–14.33) | 2.39E-07 |
| rs2736114 | T | 0.27 | 0.44 | 2.16 (1.31–3.57) | 0.01144 |
| rs2075786 | A | 0.37 | 0.36 | 0.84 (0.53–1.35) | 0.5541 |
| rs4246742 | A | 0.15 | 0.14 | 0.58 (0.27–1.22) | 0.2263 |
| rs4975605 | A | 0.47 | 0.54 | 1.43 (0.90–2.28) | 0.2038 |
| rs10069690 | T | 0.27 | 0.22 | 1.09 (0.67–1.77) | 0.7776 |
| rs2242652 | A | 0.19 | 0.19 | 1.20 (0.68–2.12) | 0.5968 |
| rs2853677 | G | 0.45 | 0.33 | 0.66 (0.41–1.06) | 0.1484 |
| rs2853676 | T | 0.29 | 0.17 | 0.48 (0.27–0.87) | 0.03968 |
| rs2853672 | C | 0.51 | 0.36 | 0.50 (0.31–0.83) | 0.02422 |
Model adjusted for maternal age, education, income, marital status, smoking status, insurance status, and sex of the infant.
SNP: single nucleotide polymorphism, MAF: minor allele frequency, pPROM: preterm premature rupture of membranes, aOR: adjusted odds ratio, CI: confidence interval
Fetal SNP and PTL association
The fetal SNP minor allele frequencies among 116 PTL cases and 346 controls and the results of the univariate analysis are found in S3 Table. The Bonferroni correction yielded a threshold of p<0.006. Of the 8 fetal SNPs analyzed, no significant associations with PTL were found in either the adjusted (Table 6) or unadjusted models (S6 Table).
Table 6. Logistic regression results for fetal single locus allele frequencies among cases and controls and association with preterm labor.
| SNP | Minor allele | MAF Term | MAF PTL | aOR (95% CI) | P |
|---|---|---|---|---|---|
| rs2736114 | T | 0.27 | 0.30 | 1.40 (0.99–1.98) | 0.1057 |
| rs2075786 | A | 0.42 | 0.42 | 0.85 (0.62–1.15) | 0.374 |
| rs4246742 | A | 0.16 | 0.15 | 0.72 (0.47–1.11) | 0.2123 |
| rs4975605 | A | 0.45 | 0.51 | 1.28 (0.95–1.72) | 0.1757 |
| rs10069690 | T | 0.27 | 0.28 | 1.07 (0.76–1.51) | 0.7532 |
| rs2242652 | A | 0.21 | 0.25 | 1.53 (1.04–2.24) | 0.06831 |
| rs2853677 | G | 0.44 | 0.49 | 1.05 (0.77–1.41) | 0.81 |
| rs2853672 | C | 0.48 | 0.48 | 0.83 (0.60–1.16) | 0.3602 |
Model adjusted for maternal education, income, smoking status, and insurance status.
SNP: single nucleotide polymorphism, MAF: minor allele frequency, PTL: preterm labor, aOR: adjusted odds ratio, CI: confidence interval
Fetal SNP and pPROM association
The fetal SNP minor allele frequencies among 40 pPROM cases and 346 controls and the results of the univariate analysis are found in S4 Table. The Bonferroni correction yielded a threshold of p<0.006. Of the 8 fetal SNPs analyzed, no significant associations with pPROM were found in either the adjusted (Table 7) or unadjusted models (S7 Table).
Table 7. Logistic regression results for fetal single locus allele frequencies among cases and controls and association with preterm premature rupture of membranes.
| SNP | Minor allele | MAF Term | MAF pPROM | aOR (95% CI) | P |
|---|---|---|---|---|---|
| rs2736114 | T | 0.27 | 0.33 | 1.41 (0.85–2.37) | 0.2611 |
| rs2075786 | A | 0.42 | 0.38 | 0.69 (0.42–1.14) | 0.2254 |
| rs4246742 | A | 0.16 | 0.18 | 0.79 (0.42–1.51) | 0.5523 |
| rs4975605 | A | 0.45 | 0.56 | 1.44 (0.90–2.30) | 0.1971 |
| rs10069690 | T | 0.27 | 0.30 | 1.21 (0.72–2.03) | 0.5508 |
| rs2242652 | A | 0.21 | 0.24 | 1.19 (0.66–2.17) | 0.6267 |
| rs2853677 | G | 0.44 | 0.30 | 0.46 (0.26–0.78) | 0.01734 |
| rs2853672 | C | 0.48 | 0.32 | 0.45 (0.26–0.78) | 0.01742 |
Model adjusted for maternal education, income, marital status, smoking status, insurance status, and sex of the infant.
SNP: single nucleotide polymorphism, MAF: minor allele frequency, pPROM: preterm premature rupture of membranes, aOR: adjusted odds ratio, CI: confidence interval
Conclusion
Feto-maternal tissue senescence is a physiological factor associated with term parturition in humans. Premature and pathologic senescence activation in response to various pregnancy-associated risk factors can contribute to preterm labor and delivery.[25] Multitudes of risk factors have been linked to premature senescence activation; mainly oxidative stress inducing factors like infection/inflammation,[32–33] obesity,[34–35] nutritional factors,[36–37] and behavioral risks.[38–39] Oxidative stress induced by these risk factors can accelerate telomere attrition causing early aging and inflammation contributing to either PTL or pPROM. Genetic variation in maternal or fetal telomerase gene may also contribute to this process in the absence of specific risk factors, or an interaction between the two may also predispose to adverse pregnancy outcome. This study examined the existence of any genetic predisposition to PTL and/or pPROM through variations in the telomerase gene.
We report that maternal hTERT SNP rs2853690 was significantly associated with both PTL (aOR 2.24) and pPROM (aOR 7.54). Located in the non-coding region near the 3 prime end, the functional role of this SNP is unclear. This SNP is not in obvious linkage disequilibrium with any other variants in hTERT (r2 < 0.36 with all other SNPs in the gene) as determined from 1000 Genomes Project data. We found no significant associations between any of the analyzed fetal hTERT SNPs and PTL or pPROM.
The major strength of our study was that the samples came from an established biobank with well-defined phenotypes and well-characterized race and ethnicity. Quality control measures were used to ensure that only subjects with high quality genotyping and only SNPs with high genotyping efficiency were included. Additionally, we analyzed both maternal and newborn samples, allowing us to investigate both the maternal and fetal contributions to risk of preterm birth. Our candidate gene, hTERT, has a biologically plausible role in the mechanisms of PTL and pPROM. And finally, a significant strength of our study is that we adjusted for multiple comparisons using the Bonferroni correction, minimizing the risk that the association we found was due to type I error.
The study was limited by small sample sizes of cases, especially pPROM. Also, the findings may not be applicable to all populations because our study was restricted to Caucasians. Of interest, the risk allele (A) is at least twice as common in African ancestry populations as compared to European populations (https://www.ncbi.nlm.nih.gov/snp/), the former being at higher risk for PTL and pPROM).[40,41] However, seemingly inconsistent results are that germline telomere length appears to be longer in African individuals that those of European descent.[30] One explanation for this could be that specific genetic predispositions vary between races/ethnicities. A replication of our data in multiple independent cohorts, particularly in one that includes people of African descent, is essential prior to projecting the usefulness of this SNP as a genetic marker of high risk pregnancy. Another limitation of this study is that we have examined only SNPs in the hTERT gene and their association with PTB and pPROM. Other genetic and epigenetic variations in the hTERT gene may also contribute to functional alterations to hTERT activity or levels, contributing to adverse pregnancy outcomes.
Telomerase’s role in uterine and feto-maternal tissues is as area of active research. In women with recurrent implantation failure, expression of endometrial telomerase was enhanced during the implantation window.[42] In pregnancy, it has been shown that hTERT expression in the chorion is increased in the first trimester compared the second and third trimesters.[43] Similarly, telomerase activity level has been shown to be significantly higher in the first trimester in chorionic villi samples.[44] A study of human fetal tissues confirms the same pattern of decreasing telomere length and decreasing telomerase expression across the first trimester.[45]
Alterations in telomerase expression/activity have been shown to be associated with pathologic pregnancy states. While increased hTERT expression was noted in chorion cells of preeclamptic patients,[43] decreased telomerase activity has been observed in trophoblasts and placental biopsies from pregnancies affected by intrauterine growth restriction.[46–47] A study of growth discordant twins showed a tendency toward reduced telomerase activity in placental trophoblasts of the smaller twin.[48] While the results are not consistent, they may suggest a link between altered telomerase expression and/or activity and premature aging of fetal tissue leading to placental insufficiency and growth restriction.
In our continued work on telomerase’s role in preterm birth, our lab has subsequently performed hTERT gene activity and expression studies. We have found that telomerase has no activity in fetal membranes in the second and third trimesters, nor is it expressed in fetal membranes from either term or preterm placenta, including laboring and non-laboring samples. The lack of telomerase expression and activity in fetal membranes could explain why we see no association between infant genetic variation in hTERT and PTL or pPROM in this study. The lack of expression is also suggestive of unhindered telomere reduction to promote the natural progression of senescence that will eventually result in parturition. This study identifies a biologically plausible candidate gene for replicative studies and contributes to the growing evidence that replicative senescence plays a role in maternal-fetal signaling of parturition.
Supporting information
MB: maternal blood, CB: cord blood, FamID: family identification number, IndID: individual identification number, GES_WGHT: birth weight.
(XLSX)
PTL: preterm labor, pPROM: preterm premature rupture of membranes.
(DOCX)
PTL: preterm labor, pPROM: preterm premature rupture of membranes.
(DOCX)
SNP: single nucleotide polymorphism, MAF: minor allele frequency, PTL: preterm birth, OR: odds ratio, CI: confidence interval.
(DOCX)
SNP: single nucleotide polymorphism, MAF: minor allele frequency, pPROM: preterm premature rupture of membranes, OR: odds ratio, CI: confidence interval.
(DOCX)
SNP: single nucleotide polymorphism, MAF: minor allele frequency, PTL: preterm labor, OR: odds ratio, CI: confidence interval.
(DOCX)
SNP: single nucleotide polymorphism, MAF: minor allele frequency, pPROM: preterm premature rupture of membranes, OR: odds ratio, CI: confidence interval.
(DOCX)
Data Availability
All relevant data and within the paper and its Supporting Information files.
Funding Statement
This study is supported by RO1 from the National Institute of Health (National Institute of Child Health and Human Development, https://www.nichd.nih.gov/Pages/index.aspx) to RM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Mathews TJ, Osterman MJ. Births: final data for 2008. Natl Vital Stat Rep 2010;59:1, 3–71. [PubMed] [Google Scholar]
- 2.Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, Requejo JH, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 2010;88:31–8. doi: 10.2471/BLT.08.062554 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science 2014;345:760–5. doi: 10.1126/science.1251816 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Menon R, Bonney EA, Condon J, Mesiano S, Taylor RN. Novel concepts on pregnancy clocks and alarms: redundancy and synergy in human parturition. Hum Reprod Update 2016;22:535–60. doi: 10.1093/humupd/dmw022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Menon R, Yu J, Basanta-Henry P, Brou L, Berga SL, Fortunato SJ, et al. Short fetal leukocyte telomere length and preterm prelabor rupture of the membranes. PLoS One 2012;7:e31136 doi: 10.1371/journal.pone.0031136 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Menon R, Behnia F, Polettini J, Saade GR, Campisi J, Velarde M. Placental membrane aging and HMGB1 signaling associated with human parturition. Aging (Albany NY) 2016;8:216–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Behnia F, Taylor BD, Woodson M, Kacerovsky M, Hawkins H, Fortunato SJ, et al. Chorioamniotic membrane senescence: a signal for parturition? Am J Obstet Gynecol 2015;213:359.e1–16. doi: 10.1016/j.ajog.2015.05.041 [DOI] [PubMed] [Google Scholar]
- 8.Hayflick L. A brief history of the mortality and immortality of cultured cells. Keio J Med 1998;47:174–82. [DOI] [PubMed] [Google Scholar]
- 9.He S, Sharpless NE. Senescence in Health and Disease. Cell 2017;169:1000–11. doi: 10.1016/j.cell.2017.05.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Varela E, Blasco MA. 2009 nobel prize in physiology or medicine: telomeres and telomerase. Oncogene 2010;29:1561–5. doi: 10.1038/onc.2010.15 [DOI] [PubMed] [Google Scholar]
- 11.Yu GL, Bradley JD, Attardi LD, Blackburn EH. In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature 1990;344:126–32. doi: 10.1038/344126a0 [DOI] [PubMed] [Google Scholar]
- 12.Blasco MA, Lee HW, Hande MP, Samper E, Landsdorp PM, DePinho RA, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997;91:25–34. [DOI] [PubMed] [Google Scholar]
- 13.Gong L, Xu Y, Hu YQ, Ding QJ, Yi CH, Huang W, et al. hTERT gene polymorphism correlates with the risk and the prognosis of thyroid cancer. Cancer Biomark 2016;17:195–204. doi: 10.3233/CBM-160631 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Bayram S, Ülger Y, Sümbül AT,Kaya BY, Genc A, Rencuzogullari E, et al. Polymorphisms in human telomerase reverse transcriptase (hTERT) gene and susceptibility to gastric cancer in a Turkish population: Hospital-based case-control study. Gene 2016;585:84–92. doi: 10.1016/j.gene.2016.03.030 [DOI] [PubMed] [Google Scholar]
- 15.Choi BJ, Yoon JH, Kim O, Choi WS, Nam SW, Lee JY, et al. Influence of the hTERT rs2736100 polymorphism on telomere length in gastric cancer. World J Gastroenterol 2015;21:9328–36. doi: 10.3748/wjg.v21.i31.9328 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Mocellin S, Verdi D, Pooley KA, Landi MT, Egan KM, Baird DM, et al. Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J Natl Cancer Inst 2012;104:840–54. doi: 10.1093/jnci/djs222 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Benetos A, Gardner JP, Zureik M, Labat C, Xiaobin L, Adamopoulos C, et al. Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension 2004;43:182–5. doi: 10.1161/01.HYP.0000113081.42868.f4 [DOI] [PubMed] [Google Scholar]
- 18.D'Mello MJ, Ross SA, Briel M, Anand SS, Gerstein H, Paré G. Association between shortened leukocyte telomere length and cardiometabolic outcomes: systematic review and meta-analysis. Circ Cardiovasc Genet 2015;8:82–90. doi: 10.1161/CIRCGENETICS.113.000485 [DOI] [PubMed] [Google Scholar]
- 19.Codd V, Nelson CP, Albrecht E, Mangino M, Deelan J, Buxton JL, et al. Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet 2013;45:422–7, 7e1-2. doi: 10.1038/ng.2528 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Herrera E, Samper E, Martín-Caballero J, Flores JM, Lee HW, Blasco MA. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J 1999;18:2950–60. doi: 10.1093/emboj/18.11.2950 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Lee HW, Blasco MA, Gottlieb GJ, Horner JW, Greider CW, DePinho RA. Essential role of mouse telomerase in highly proliferative organs. Nature 1998;392:569–74. doi: 10.1038/33345 [DOI] [PubMed] [Google Scholar]
- 22.Haycock PC, Burgess S, Nounu A, Zheng J, Okoli GN, Bowden J, et al. Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study. JAMA Oncol 2017;3:636–51. doi: 10.1001/jamaoncol.2016.5945 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Zhang W, Chen Y, Yang X, Fan J, Mi X, Wang J, et al. Functional haplotypes of the hTERT gene, leukocyte telomere length shortening, and the risk of peripheral arterial disease. PLoS One 2012;7:e47029 doi: 10.1371/journal.pone.0047029 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Mangino M, Brouilette S, Braund P, Tirmizi N, Vasa-Nicotera M, Thompson JR, et al. A regulatory SNP of the BICD1 gene contributes to telomere length variation in humans. Hum Mol Genet 2008;17:2518–23. doi: 10.1093/hmg/ddn152 [DOI] [PubMed] [Google Scholar]
- 25.Dutta EH, Behnia F, Boldogh I, Saade GR, Taylor BD, Kacerovsky M, et al. Oxidative stress damage-associated molecular signaling pathways differentiate spontaneous preterm birth and preterm premature rupture of the membranes. Mol Hum Reprod 2016;22:143–57. doi: 10.1093/molehr/gav074 [DOI] [PubMed] [Google Scholar]
- 26.Hirota Y, Daikoku T, Tranguch S, Xie H, Bradshaw HB, Dey SK. Uterine-specific p53 deficiency confers premature uterine senescence and promotes preterm birth in mice. J Clin Invest 2010;120:803–15. doi: 10.1172/JCI40051 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Romero R, Friel LA, Velez Edwards DR, Kusanovic JP, Hassan SS, Mazaki-Tovi S, et al. A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM). Am J Obstet Gynecol 2010;203:361.e1–.e30. doi: 10.1016/j.ajog.2010.05.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Velez DR, Fortunato S, Thorsen P, Lombardi SJ, Williams SM, Menon R. Spontaneous preterm birth in African Americans is associated with infection and inflammatory response gene variants. Am J Obstet Gynecol 2009;200:209.e1–27. doi: 10.1016/j.ajog.2008.08.051 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Menon R, Pearce B, Velez DR, Merialdi M, Williams SM, Fortunato SJ, et al. Racial disparity in pathophysiologic pathways of preterm birth based on genetic variants. Reprod Biol Endocrinol 2009;7:62 doi: 10.1186/1477-7827-7-62 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Hansen ME, Hunt SC, Stone RC, Horvath K, Herbig U, Ranciaro A, et al. Shorter telomere length in Europeans than in Africans due to polygenetic adaptation. Hum Mol Genet 2016;25:2324–30. doi: 10.1093/hmg/ddw070 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Stone RC, Horvath K, Kark JD, Susser E, Tishkoff SA, Aviv A. Telomere Length and the Cancer-Atherosclerosis Trade-Off. PLoS Genet 2016;12:e1006144 doi: 10.1371/journal.pgen.1006144 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Chuprin A, Gal H, Biron-Shental T, Biran A, Amiel A, Rozenblatt S, et al. Cell fusion induced by ERVWE1 or measles virus causes cellular senescence. Genes Dev 2013;27:2356–66. doi: 10.1101/gad.227512.113 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Martínez I, García-Carpizo V, Guijarro T, Garcia-Gomez A, Navarro D, Aranda A, et al. Induction of DNA double-strand breaks and cellular senescence by human respiratory syncytial virus. Virulence 2016;7:427–42. doi: 10.1080/21505594.2016.1144001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Tobler K, Freudenthaler A, Baumgartner-Parzer SM, Wolzt M, Ludvik B, Nansalmaa E, et al. Reduction of both number and proliferative activity of human endothelial progenitor cells in obesity. Int J Obes (Lond) 2010;34:687–700. [DOI] [PubMed] [Google Scholar]
- 35.Brodsky SV, Gealekman O, Chen J, Zhang F, Togashi N, Crabtree M, et al. Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen. Circ Res 2004;94:377–84. doi: 10.1161/01.RES.0000111802.09964.EF [DOI] [PubMed] [Google Scholar]
- 36.Dong D, Cai GY, Ning YC, Wang JC, Lv Y, Hong Q, et al. Alleviation of senescence and epithelial-mesenchymal transition in aging kidney by short-term caloric restriction and caloric restriction mimetics via modulation of AMPK/mTOR signaling. Oncotarget 2017;8:16109–21. doi: 10.18632/oncotarget.14884 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Shi Q, Hubbard GB, Kushwaha RS, Rainwater D, Thomas CA 3rd, Leland MM, et al. Endothelial senescence after high-cholesterol, high-fat diet challenge in baboons. Am J Physiol Heart Circ Physiol 2007;292:H2913–20. doi: 10.1152/ajpheart.01405.2006 [DOI] [PubMed] [Google Scholar]
- 38.Zhou F, Onizawa S, Nagai A, Aoshiba K. Epithelial cell senescence impairs repair process and exacerbates inflammation after airway injury. Respir Res 2011;12:78 doi: 10.1186/1465-9921-12-78 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Zhang L, Wu R, Dingle RW, Gairola CG, Valentino J, Swanson HI. Cigarette smoke condensate and dioxin suppress culture shock induced senescence in normal human oral keratinocytes. Oral Oncol 2007;43:693–700. doi: 10.1016/j.oraloncology.2006.08.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Culhane JF, Goldenberg RL. Racial disparities in preterm birth. Semin Perinatol 2011;35:234–9. doi: 10.1053/j.semperi.2011.02.020 [DOI] [PubMed] [Google Scholar]
- 41.Shen TT, DeFranco EA, Stamilio DM, Chang JJ, Muglia LJ. A population-based study of race-specific risk for preterm premature rupture of membranes. Am J Obstet Gynecol 2008;199:373.e1–7. doi: 10.1016/j.ajog.2008.05.011 [DOI] [PubMed] [Google Scholar]
- 42.Long N, Liu N, Liu XL, Li J, Cai BY, Cai X. Endometrial expression of telomerase, progesterone, and estrogen receptors during the implantation window in patients with recurrent implantation failure. Genet Mol Res 2016;15. [DOI] [PubMed] [Google Scholar]
- 43.Akutagawa O, Nishi H, Kyo S, Higuma C, Inoue M, Isaka K. Early growth response-1 mediates up-regulation of telomerase in placenta. Placenta 2007;28:920–7. doi: 10.1016/j.placenta.2007.03.005 [DOI] [PubMed] [Google Scholar]
- 44.Nishi H, Yahata N, Ohyashiki K, Isaka K, Shiraishi K, Ohyashiki JH, et al. Comparison of telomerase activity in normal chorionic villi to trophoblastic diseases. Int J Oncol 1998;12:81–5. [DOI] [PubMed] [Google Scholar]
- 45.Cheng G, Kong F, Luan Y, Sun C, Wang J, Zhang L, et al. Differential shortening rate of telomere length in the development of human fetus. Biochem Biophys Res Commun 2013;442:112–5. doi: 10.1016/j.bbrc.2013.11.022 [DOI] [PubMed] [Google Scholar]
- 46.Biron-Shental T, Kidron D, Sukenik-Halevy R, Goldberg-Bittman L, Sharoney R, Fejgin MD, et al. TERC telomerase subunit gene copy number in placentas from pregnancies complicated with intrauterine growth restriction. Early Hum Dev 2011;87:73–5. doi: 10.1016/j.earlhumdev.2010.08.024 [DOI] [PubMed] [Google Scholar]
- 47.Biron-Shental T, Sukenik Halevy R, Goldberg-Bittman L, Kidron D, Fejgin MD, Amiel A. Telomeres are shorter in placental trophoblasts of pregnancies complicated with intrauterine growth restriction (IUGR). Early Hum Dev 2010;86:451–6. doi: 10.1016/j.earlhumdev.2010.06.002 [DOI] [PubMed] [Google Scholar]
- 48.Kim SY, Lee SP, Lee JS, Yoon SJ, Jun G, Hwang YJ. Telomerase and apoptosis in the placental trophoblasts of growth discordant twins. Yonsei Med J 2006;47:698–705. doi: 10.3349/ymj.2006.47.5.698 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
MB: maternal blood, CB: cord blood, FamID: family identification number, IndID: individual identification number, GES_WGHT: birth weight.
(XLSX)
PTL: preterm labor, pPROM: preterm premature rupture of membranes.
(DOCX)
PTL: preterm labor, pPROM: preterm premature rupture of membranes.
(DOCX)
SNP: single nucleotide polymorphism, MAF: minor allele frequency, PTL: preterm birth, OR: odds ratio, CI: confidence interval.
(DOCX)
SNP: single nucleotide polymorphism, MAF: minor allele frequency, pPROM: preterm premature rupture of membranes, OR: odds ratio, CI: confidence interval.
(DOCX)
SNP: single nucleotide polymorphism, MAF: minor allele frequency, PTL: preterm labor, OR: odds ratio, CI: confidence interval.
(DOCX)
SNP: single nucleotide polymorphism, MAF: minor allele frequency, pPROM: preterm premature rupture of membranes, OR: odds ratio, CI: confidence interval.
(DOCX)
Data Availability Statement
All relevant data and within the paper and its Supporting Information files.